Swimming goggles increase IOP

Article

A study published in the September issue of the British Journal of Ophthalmology, has discovered that wearing swimming goggles may elevate intraocular pressure (IOP).

A study published in the September issue of the British Journal of Ophthalmology, has discovered that wearing swimming goggles may elevate intraocular pressure (IOP).

W.H. Morgan and colleagues from the Lions Eye Institute, University of Western Australia, Australia conducted a study to determine whether wearing swimming goggles increases IOP.

Holes were drilled into 13 different goggles to allow IOP measurement by applanation tonometry. IOP measurements were taken before goggle wear, two minutes after the goggles were put on, 20 minutes after and following the removal of the goggles.

It was discovered that IOP increased by a mean pressure of 4.5 mmHg (p<0.001) while goggles were being worn, with the pressure being sustained for the duration. It was also found that a smaller goggle face area (p=0.013) was associated with greater IOP elevations.

Although measurements were not taken while swimming, the results of this study indicate that wearing goggles will elevate IOP.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.